The Effect of Salutogenic-based Interviewing on Subjective Recovery and Quality of Life in Schizophrenia
NCT ID: NCT06820580
Last Updated: 2025-02-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
60 participants
INTERVENTIONAL
2025-02-20
2025-12-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
With the discovery of antipsychotic drugs, the symptoms of the disease were alleviated, the level of severity decreased and the length of hospitalization was shortened. However, this led to repeated hospitalizations of patients with chronic course and a revolving door effect occurred. Drug treatment has a limited effect on readjustment to society, improving social relations and increasing self-care activities in individuals with chronic mental illness. Therefore, it is important to support drug treatment with social support programs and various psychosocial approaches. In the past, pathogenic approaches focusing on problems and risk factors have been adopted to promote and maintain health. The salutogenic model developed by medical sociologist Aaron Antonovsky (1987) focuses on the causes of health rather than the factors that cause disease. This model is concerned with the relationship between how people approach stressful situations (such as mental and chronic health conditions and their consequences) and their individual ability to self-manage and cope with these situations. The model is a medical approach that focuses on the causes of health rather than the factors that cause disease.
This study was planned to evaluate the effect of salutogenic approach-based interviewing on subjective recovery and quality of life in individuals diagnosed with schizophrenia.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Salutogenic Approach Based Interview With People With Schizophrenia
NCT04740944
The Effect of Mindfulness-Based Psychoeducation Programme Given Individually to Schizophrenia Patients on Internalised Stigma and Healthy Lifestyle Behaviours
NCT06882538
The Effect of Psychoeducation Program on Healthy Living Behaviors
NCT05208021
The Effect of Psychoeducation on Healthy Lifestyle Behaviors in Individuals With Schizophrenia
NCT05259748
The Effect of Psychosocial Skills Focused Group Psychoeducation in Schizophrenia Patients
NCT06872424
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The similarity between the core principle of the salutogenic model and the professional purpose of psychiatric nursing is striking. Psychiatric nursing supports the protection and promotion of community mental health, the rehabilitation of disorders and the regaining of the ability to cope with the experiences of suffering and to find meaning in life. Therefore, the model is suitable for many practice areas of psychiatric nurses.
The increasing number of people living with mental health problems in society for many years focuses on the need for recovery from a coping and mental health promotion perspective. The value of salutogenic theory is that it emphasizes coping and health promotion. Although there are numerous empirical applications of salutogenic theory in the field of public health, reviews of salutogenic-based interventions and their impact on population health are limited. Through the salutogenic method, examining deep challenges can provide opportunities to understand how individuals cope during crises and suggest methods to improve the health of the general population. As nursing education and intervention, it is important in terms of emphasizing the need for health promotion and ultimately promoting normal physical and psychological health.
The motto of the Mental Health Action Plan for 2021-2023 is stated as "Implementing an integrated community-based mental health service model in mental health services, monitoring, protecting and improving the mental health of individuals". Subjective recovery is a personally perceived improvement that includes other factors beyond clinical recovery. These factors focus on areas of personal development such as empowerment, having a sense of hope, having confidence in the future, redefining oneself, overcoming stigmatization, establishing supportive relationships, taking responsibility, giving meaning to life and leading a fulfilling life. Subjective well-being and quality of life are increasingly recognized as important treatment outcomes in patients with schizophrenia. Schizophrenia, which usually lasts a lifetime, is a disorder that causes significant problems in quality of life and functioning. Factors such as physical health, adaptability, well-being, economic status and social interaction are among the components of quality of life.
Therefore, this study was planned to evaluate the effect of salutogenic approach-based interviewing on subjective recovery and quality of life in individuals diagnosed with schizophrenia.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
Experimental group Control group Individuals in the experimental group will be subjected to a four-week training program and assessments will be made twice, before and after the training. In the control group, no training will be given and the assessments will be conducted twice, four weeks apart.
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Salutogenic Approach Based Interview Group
Participants will be offered an 8-session Salutogenic Approach Based Interview Program two days a week.
Salutogenic Approach Based Interview
Salutogenic Approach Based Interviewing Program consists of 8 sessions. The interview will be conducted for four weeks and on two specific days of the week. Interviews will be conducted in groups of 6-8 people. The interview will last 30-40 minutes on average.
Control group
There will be no intervention interview. They will continue their normal routines and treatments at the community mental health center.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Salutogenic Approach Based Interview
Salutogenic Approach Based Interviewing Program consists of 8 sessions. The interview will be conducted for four weeks and on two specific days of the week. Interviews will be conducted in groups of 6-8 people. The interview will last 30-40 minutes on average.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The participant is in the recovery (remission) period
* Being diagnosed with schizophrenia
* Being suitable for group work
Exclusion Criteria
* Presence of hearing and comprehension problems
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ataturk University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Şeyda Erçel
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Şeyda Erçel, MSc
Role: PRINCIPAL_INVESTIGATOR
Ataturk University
Sibel Asi Karakaş
Role: PRINCIPAL_INVESTIGATOR
Ataturk University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Elazığ Community Mental Health Center
Elâzığ, Province, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AU-SBF-ŞE-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.